L-Nutra
  • About us
    • About L-Nutra
    • Italian Team
  • Fasting Mimicking Diet
  • Scientific research
    • Scientific Articles
    • List of Clinical Trials
  • Products
    • ProLon
    • Fast Bar
  • Newsroom
  • Contact Us
  • Search
  • Menu

List of Clinical Trials

Trial 1

Safety, Feasibility and Metabolic Effects of the Fasting Mimicking Diet (FMD) in Cancer Patients

Trial 2

Impact of Dietary Intervention on Tumor Immunity – The DlgesT Trial

Trial 3

Os-10-3 — A Randomized, Phase II Clinical Trial of a Controlled Diet Prior to Selected Chemotherapy Treatment in Breast and Prostate Cancer to Evaluate the Impact on Toxicity and Efficacy

Trial 4

Phase II Study of a Diet that Simulates Fasting in Patients Undergoing Cancer Treatment

Trial 5

BRCA Main Home Study — Use of FMD in a Group of People Who Carry Mutations in Susceptibility Genes for Breast Cancer

Trial 6

Dietary Restriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer (DIRECT)

Trial 7

Fasting and Nutritional Therapy in Patients with Advanced Metastatic Prostate Cancer

Trial 8

Fasting and Cancer Treatment in Humans — A Case Series Report

Trial 9

Effects of Short-Term Fasting on Tolerance to Adjuvant Chemotherapy in Breast Cancer Patients

Trial 10

Short-Term Fasting Prior To Platinum-Based Chemotherapy — Feasibility and Impact on Toxicity

Trial 11

Short-Term Fasting During Chemotherapy in Patients with Gynecological Cancer — A Randomized Controlled Cross-over Trial (FIT)

Trial 12

Fasting Mimicking Diet in Patients Receiving Chemo-Immunotherapy for Treatment of Metastatic Non-Small Cell Lung Cancer

Trial 13

Fasting Mimicking Diet on Central and Peripheral Components of Fatigue, Muscular Resistance

Trial 14

Primitive Glomerulonephritis and Chronic Kidney Disease in Conservative Therapy with eGFR ≤ 60 ml/min (3 stage kdoqi)

Trial 15

The Randomized Pilot Study to Evaluate the Efficacy and Safety of ProLon, a Fasting Mimicking Diet, as Add-On Therapy in Hashimoto’s Thyroiditis.

Trial 16

Randomized Phase I/II Study of a Hypoproteic Diet in Patients with Cognitive Impairment

Trial 17

Multiple Sclerosis

Trial 18

Studio Randomizzato di Fase I/II di una Dieta Ipoproteica in Pazienti con Sindrome Metabolica

Trial 19

Safety and Feasibility of Fasting in Combination with Platinum-Based Chemotherapy

Trial 20

To Evaluate the Efficacy and Safety of ProLon, a Fasting Mimicking Diet on Metabolic Syndrome

Trial 21

Evaluate the Efficacy and Safety of a Fasting Mimicking Diet, as Add-On Therapy, on Clinical Response in Patients with Active, Mild to Moderate Ulcerative Colitis

Trial 22

Evaluate the Efficacy and Safety of a Fasting Mimicking Diet, as Add-On Therapy, on Clinical Response in Patients with Active Crohn’s Disease

Trial 23

Five Meals a Day vs. Two Meals a Day — To Evaluate the Consumption of Two Meals Plus One Snack per Day Compared to Five Meals per Day on Initial Weight Loss and Weight Maintenance over the Period of 12 Months in Overweight and Obese Individuals (with BMI > 27)

Trial 24

Fasting Mimicking Diet Study Protocol

Trial 25

PCI.GC.002 — A Prospective Pilot Cohort Study of Patients with a Known Diagnosis of Cancer, to Document its Metabolic Effects, including Cancer Fatigue, and Metabolic Syndrome, as well as Lifestyle Changes in the Clinic

Trial 26

Fasting Mimicking Diet, Modified Ketogenic Diet, and Time Restricted Feedings as Adjuvant Therapy for Newly Diagnosed Glioblastoma Multiforme Patients

Trial 27

The Effect of Dietary Interventions on Endothelial Glycocalyx Dimensions and Barrier Function in South Asian Patients with Diabetic Nephropathy (Glycotreat Study)

Trial 28

Chronic Fasting and the Late Complications of Diabetes: A Prospective Explanatory Randomized Controlled Study in Patients with Diabetes Mellitus Type 2

Trial 29

Pilot Study on the Effects of Fasting Mimicking Diet (FMD) in Women with Polycystic Ovary Syndrome (PCOS)

Trial 30

Fasting Mimicking Diet — A Randomized Trial on Feasibility, Safety and Effects of Multicycle Dietary Intervention on Side Effects of Aromatase Inhibitors Treatment in Post-Menopausal Patients with Breast Cancer

Trial 31

Phase I, Pilot, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ProMet, a Fasting Mimicking Diet, on Inflammatory Cardiomyopathy

Trial 32

Cephalalgy

Trial 33

Melanoma Immunotherapy and FMD

Trial 34

Depression

Trial 35

Liver Transplant

Trial 36

Obesity-Associated Olfact Deficit and FMD

Trial 37

Bariatric Surgery

Trial 38

Pedriatic Type 1 Diabetes

Trial 39

Colorectal

Trial 40

Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes — Fasting in Diabetes Treatment (FIT) Study

Trial 41

FMD and Insulin Resistant Adolescents (Females)

Trial 42

FMD AND IBD

Via XX Settembre, 12/2E - 16121
GENOVA (GE), ITALIA P.I 02140480993

(+39) 3271180483

FOLLOW US

facebook twitter youtube linkedin

HEALTH CARE PROVIDERS

Health Care Providers interested in authorizing ProLon® for their patients can Register on the their national ProLon® website.

DISCLAIMER

The statements on this site have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

PEOPLE AFFECTED BY DIABETES

WARNING RELATED TO OUR RECENT STUDIES ON DIABETES: DO NOT TRY TO APPLY ANY TYPE OF FASTING MIMICKING DIET TO TREAT EITHER TYPE 1 OR TYPE 2 DIABETES ALONE OR EVEN WITH THE HELP OF A DOCTOR. THE COMBINATION OF THE FMD AND INSULIN BUT ALSO OTHER DRUGS COULD CAUSE SEVERE PROBLEMS. ALTHOUGH THE USE OF THE FMD TO TREAT EITHER TYPE 1 OR 2 DIABETES IS PROMISING, IT MUST BE FIRST TESTED AND PROVEN EFFECTIVE IN FDA CLINICAL TRIALS WHICH WILL PROBABLY REQUIRE HOSPITALIZATION DURING THE TREATMENT.

Copyright © L-Nutra Inc.
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OK